摘要目的 探究Superpath入路和Hardinge入路在初次微创全髋关节置换术的中期随访效果。方法 选取我院2013年1月至2014年1月期间收治的38例择期人工髋关节置换术患者,根据手术入路分为Superpath组(S组)和Hardinge组(H组),每组各19例。记录两组围术期指标,并对两组患者进行随访至术后3年,采用疼痛视觉模拟评分(visual analogue scale,VAS),纽约特种外科医院关节评分(hospital for special surgery score,HSS),以及Harris髋关节评分对患者进行评价,并统计发生假体脱位、骨溶解等中期并发症的人数。结果 S组的手术时间、术中失血量高于H组,住院时间少于H组(P<0.05),两组术后引流量、输血率比较,差异无统计学意义(P>0.05);两组术后VAS、HSS、Harris评分在术后1年内均明显改善;S组在术后1年内的VAS评分均低于H组,HSS评分均高于H组(P<0.05),但两组在术后3年的VAS、HSS评分无明显差异(P>0.05);S组的Harris评分始终均高于H组(P<0.05)。结论 Superpath入路与传统入路手术相比,手术时间长、失血量较高,但其恢复较快,短期内VAS、HSS、Harris评分改善更加明显,且中期关节功能更好。
[1]颜廷题,田少奇,王远贺,等.Superpath与Hardinge入路全髋关节置换术早期临床疗效比较[J].中国修复重建外科杂志,2017,31(1):17-24.
[2]任东伟,杨革军,赵华磊,等.Superpath切口微创人工全髋关节置换术对股骨头坏死疗效及生活质量的影响[J].河北医科大学学报,2016,37(12):1416-1419.
[3]Cronin MD,Gofton W,Erwin L,et al.Early surgical and functional outcomes comparison of the super capsular percutaneously-assisted total hip and traditional posterior surgical techniques for total hip arthroplasty:protocol for a randomized,controlled study[J].Annals of translational medicine,2015,3(21):335.
[4]蒋守海,邱东新,朱信飞,等.SuperPATH入路微创全髋关节置换术的初步应用[J].中国骨与关节损伤杂志,2016,31(12):1290-1291.
[5]侯靖钊,包洪卫,程彦晓.应用SuperPATH技术行全髋关节置换的早期疗效观察[J].临床骨科杂志,2017,20(1):50-53.
[6]Chow J,Penenberg B,Murphy S.Modified micro-superior percutaneously-assisted total hip:early experiences & case reports[J].Current Reviews in Musculoskeletal Medicine,2011,4(3):146-150.
[7]孙帆,赵小林.Hardinge入路人工全髋关节置换术治疗髋关节骨关节病临床分析[J].中国卫生标准管理,2016,7(9):63-64.
[8]梁晓雨,李晓光,薛探.Superpath微创伤全髋关节置换术于临床应用中的研究[J].中华肿瘤防治杂志,2016,23(S2):277-278.
[9]姚坚,丁海.Superpath微创人工全髋关节置换术的研究进展[J].中国修复重建外科杂志,2016,30(9):1170-1173.
[10]吴良浩,禹宝庆,陈帆成.Superpath微创入路人工股骨头置换治疗老年股骨颈骨折:前瞻性、开放性、随机对照临床试验[J].中国组织工程研究,2017,21(7):1009-1014.
[11]Bodrogi AW,Sciortino R,Fitch DA,et al.Use of the supercapsularpercutaneously assisted total hip approach for femoral neck fractures:surgical technique and case series[J].Journal of Orthopaedic Surgery and Research,2016,11(113):1-6.
[12]CardenasN C,Bellotti V,Astarita E.Innovative approach in total hip arthroplasty:supercapsularpercutaneously-assisted[J].Hip Int,2016,26(Suppl 1):34-37.
[13]Rasuli KJ,Gofton W.Percutaneously assisted total hip(Path) and Supercapsularpercutaneously assisted total hip(Superpath) arthroplasty:learning curves and early outcomes[J].Ann Transl Med,2015,3(13):179.
[14]胡方煜,赖仁欢,梁木荣,等.Superpath入路微创人工全髋关节置换术的临床应用[J].微创医学,2016,11(3):416-418.
[15]Gofton W,Chow J,Olsen KD,et al.Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsularpercutaneously-assisted total hip surgical technique[J].Inter Orthop,2015,39(5):847-851.